J

Jaguar Health
D

JAGX

1.04000
USD
0.07
(6.95%)
Market Closed
Volume
1,594
EPS
-0
Div Yield
-
P/E
0
Market Cap
12,270,220
Related Instruments
    A
    ACER
    0
    (0%)
    0.000000 USD
    A
    ADMP
    0
    (0%)
    0.000000 USD
    A
    AGEN
    -0.05000
    (-1.80%)
    2.72500 USD
    A
    AKRO
    -1.660
    (-5.58%)
    28.070 USD
    A
    APLT
    -0.32500
    (-3.61%)
    8.68000 USD
    A
    ASRT
    -0.03000
    (-3.57%)
    0.81000 USD
    A
    AVXL
    -0.57500
    (-7.17%)
    7.45000 USD
    A
    AXGN
    0.185
    (1.48%)
    12.670 USD
    B
    BGNE
    -4.220
    (-2.18%)
    189.320 USD
    B
    BNGO
    -0.00920
    (-3.60%)
    0.24620 USD
    More
News

Title: Jaguar Health Inc.

Sector: Healthcare
Industry: Biotechnology
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.